You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
Timeline
Attention Score in Context
Title |
Safe and Effective Subcutaneous Self-Injection of Bimekizumab with Safety Syringe and Auto-Injector Devices: Results from a Multicenter, Randomized, Open-Label Study in Patients with Psoriatic Arthritis
|
---|---|
Published in |
Patient preference and adherence, October 2023
|
DOI | 10.2147/ppa.s427809 |
Pubmed ID | |
Authors |
Alan Kivitz, Alicia M Ellis, Vishvesh Shende, Jérémy Lambert, Daljit Tatla |
Attention Score in Context
This research output has an Altmetric Attention Score of 7. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 09 October 2023.
All research outputs
#5,139,807
of 26,589,077 outputs
Outputs from Patient preference and adherence
#327
of 1,781 outputs
Outputs of similar age
#84,048
of 370,271 outputs
Outputs of similar age from Patient preference and adherence
#5
of 20 outputs
Altmetric has tracked 26,589,077 research outputs across all sources so far. Compared to these this one has done well and is in the 79th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 1,781 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 7.9. This one has done well, scoring higher than 78% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 370,271 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 76% of its contemporaries.
We're also able to compare this research output to 20 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 70% of its contemporaries.